1 Year Total Returns (Daily) Chart

View 1 Year Total Returns (Daily) for ENLV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View 1 Year Total Returns (Daily) Chart
Start Trial

Historical 1 Year Total Returns (Daily) Data

View and export this data back to 2015. Start Trial.
Date Value
September 08, 2026 -92.88%
September 04, 2026 -93.15%
September 03, 2026 -92.70%
September 02, 2026 -92.14%
September 01, 2026 -91.87%
August 31, 2026 -91.87%
August 28, 2026 -91.35%
August 27, 2026 -90.98%
August 26, 2026 -90.65%
August 25, 2026 -90.62%
August 24, 2026 -90.41%
August 21, 2026 -90.49%
August 20, 2026 -90.91%
August 19, 2026 -89.02%
August 18, 2026 -91.89%
August 17, 2026 -94.21%
August 14, 2026 -94.08%
August 13, 2026 -92.78%
August 12, 2026 -92.19%
August 11, 2026 -91.29%
August 10, 2026 -90.63%
August 07, 2026 -89.73%
August 06, 2026 -90.22%
August 05, 2026 -89.54%
August 04, 2026 -90.50%
Date Value
August 03, 2026 -90.02%
July 31, 2026 -90.65%
July 30, 2026 -91.56%
July 29, 2026 -89.44%
July 28, 2026 -88.15%
July 27, 2026 -74.69%
July 24, 2026 -75.48%
July 23, 2026 -75.16%
July 22, 2026 -74.10%
July 21, 2026 -73.50%
July 20, 2026 -74.01%
July 17, 2026 -74.00%
July 16, 2026 -74.25%
July 15, 2026 -68.35%
July 14, 2026 -68.49%
July 13, 2026 -65.26%
July 10, 2026 -65.87%
July 09, 2026 -62.05%
July 08, 2026 -59.28%
July 07, 2026 -59.17%
July 06, 2026 -56.60%
July 02, 2026 -53.31%
July 01, 2026 -51.64%
June 30, 2026 -50.90%
June 29, 2026 -51.67%

Total Return Definition

The Total return is the change in price over a specific period of time that includes dividends and distributions paid.

Read full definition.

1 Year Total Returns (Daily) Range, Past 5 Years

View 1 Year Total Returns (Daily) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

1 Year Total Returns (Daily) Benchmarks

View 1 Year Total Returns (Daily) Benchmarks
Start Trial
Polyrizon Ltd. 86.00%
NovelStem International Corp. -47.22%
Brainstorm Cell Therapeutics, Inc. 41.35%
Summit Therapeutics, Inc. -11.13%
PeptiDream Inc. -36.36%